Baird Financial Group, Inc. Quidel Ortho Corp Transaction History

Baird Financial Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$41.76 - $74.73 $1.79 Million - $3.21 Million	-42,933 Reduced 37.96%	70,170 $3.36 Million
Q4 2023 Feb 14, 2024	BUY	$58.16 - $75.44 $1.27 Million - $1.65 Million	21,845 Added 23.94%	113,103 $8.34 Million
Q3 2023 Nov 13, 2023	SELL	$70.9 - $88.63 $228,581 - $285,743	-3,224 Reduced 3.41%	91,258 $6.67 Million
Q2 2023 Aug 11, 2023	SELL	$81.09 - $94.16 $1.54 Million - $1.78 Million	-18,951 Reduced 16.71%	94,482 $7.83 Million
Q1 2023 May 15, 2023	BUY	$82.98 - $91.46 $2.6 Million - $2.87 Million	31,390 Added 38.26%	113,433 $10.1 Million
Q3 2022 Nov 14, 2022	BUY	$69.86 - $107.63 $156,905 - $241,736	2,246 Added 2.84%	81,434 $5.82 Million
Q2 2022 Aug 08, 2022	BUY	$89.06 - $117.64 $7.05 Million - $9.32 Million	79,188 New	79,188 $7.7 Million

293

67.9M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.69B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.